Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014632
Filing Date
2024-11-06
Accepted
2024-11-06 16:16:30
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20240930x10q.htm   iXBRL 10-Q 1449280
2 EX-31.1 gbio-20240930xex31d1.htm EX-31.1 7624
3 EX-31.2 gbio-20240930xex31d2.htm EX-31.2 8141
4 EX-32.1 gbio-20240930xex32d1.htm EX-32.1 4734
5 EX-32.2 gbio-20240930xex32d2.htm EX-32.2 5321
  Complete submission text file 0001558370-24-014632.txt   5902006

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20240930.xsd EX-101.SCH 41239
7 EX-101.CAL gbio-20240930_cal.xml EX-101.CAL 49513
8 EX-101.DEF gbio-20240930_def.xml EX-101.DEF 188863
9 EX-101.LAB gbio-20240930_lab.xml EX-101.LAB 331410
10 EX-101.PRE gbio-20240930_pre.xml EX-101.PRE 286507
69 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20240930x10q_htm.xml XML 927122
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 241431208
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)